Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIO101 for Muscle Strength in Obese Patients on Semaglutide
NCT07411378Phase 2Not yet recruiting
- Sponsor
- Biophytis
- Start
- Jul 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of 20-hydroxyecdysone in muscle atrophy, sponsored by Biophytis. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
20-hydroxyecdysone
03
Conditions
muscle atrophy
Beyond the preview
Go deeper on NCT07411378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07411378.